自身抗体阴性1型糖尿病的临床、免疫遗传与代谢特征
该研究比较了26例自身抗体阴性1型糖尿病与30例自身抗体阳性1型糖尿病及25例血糖正常对照者的特征。结果显示两组在诊断年龄、病程、BMI、免疫表型、GRS2评分及β细胞功能(胰高血糖素和混合餐刺激)方面均无显著差异,提示自身抗体阴性1型糖尿病与抗体阳性者具有相似的临床、免疫、遗传和代谢特征。
要点
- 自身抗体阴性1型糖尿病与抗体阳性者在诊断年龄、病程和BMI上无显著差异。
- 两组间免疫表型、GRS2评分及β细胞功能(C肽反应)均相似。
- 提示自身抗体阴性1型糖尿病可能并非独立亚型,临床管理可参考抗体阳性者。
核心结论
- 成人自身抗体阴性1型糖尿病与抗体阳性者具有相似的临床、免疫、遗传和代谢特征。
研究设计与样本
- 研究纳入26例自身抗体阴性1型糖尿病、30例自身抗体阳性1型糖尿病和25例血糖正常对照,进行临床特征和深度免疫表型分析。
- 遗传风险采用1型糖尿病遗传风险评分2(GRS2)评估,并与自身抗体阳性1型糖尿病和成人隐匿性自身免疫糖尿病比较。
- 对29例新发1型糖尿病患者纵向评估β细胞功能(胰高血糖素刺激试验),部分受试者行混合餐试验。
主要发现
- 自身抗体阴性与阳性组诊断年龄分别为33.5±11.6岁和31.6±9.3岁(p=0.78),病程中位数均为3年(IQR 1-6),BMI分别为24.1±3.4和23.4±2.9 kg/m2(p=0.82)。
- 免疫表型分析未发现显著差异。
- 平均GRS2评分在自身抗体阴性组为19.6,阳性组为19.4。
- 胰高血糖素刺激后峰值C肽分别为0.25 [0.13-0.38] nmol/l和0.30 [0.20-0.55] nmol/l(p=0.27);混合餐刺激后C肽AUC分别为1.46±0.29和1.45±0.31 nmol/l×min(p>0.99)。
临床怎么用
- 对于自身抗体阴性的1型糖尿病成人患者,其临床特征与抗体阳性者相似,可参照抗体阳性1型糖尿病进行管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Autoantibody-negative type 1 diabetes is an idiopathic subtype with unclear aetiology. We aimed to characterise and compare the clinical, immune, genetic and metabolic characteristics of individuals with autoantibody-negative vs autoantibody-positive type 1 diabetes. METHODS: Clinical features and deep immune phenotyping of 26 individuals with autoantibody-negative type 1 diabetes were analysed and compared with 30 individuals with autoantibody-positive type 1 diabetes and 25 normoglycaemic control participants. Genetic risk was assessed using the type 1 diabetes genetic risk score 2 (GRS2) and compared with individuals with autoantibody-positive type 1 diabetes and latent autoimmune diabetes in adults. Beta cell function was longitudinally assessed in 29 participants with recent-onset type 1 diabetes using glucagon stimulation tests. Mixed meal tests were performed on a subset of participants. RESULTS: Participants with autoantibody-negative and autoantibody-positive type 1 diabetes had similar age at diagnosis (33.5 ± 11.6 vs 31.6 ± 9.3 years, p=0.78), disease duration (median 3 [IQR 1-6] years for both) and BMI (24.1 ± 3.4 vs 23.4 ± 2.9 kg/m2, p=0.82). Immune phenotyping revealed no significant differences. Mean GRS2 scores were comparable (19.6 in autoantibody-negative type 1 diabetes vs 19.4 in autoantibody-positive type 1 diabetes). Beta cell function was also similar in response to glucagon (peak C-peptide 0.25 [0.13-0.38] vs 0.30 [0.20-0.55] nmol/l, respectively, p=0.27) and mixed meal stimuli (C-peptide AUC 1.46 ± 0.29 vs 1.45 ± 0.31 nmol/l × min, respectively, p>0.99). CONCLUSIONS/INTERPRETATION: Adults with autoantibody-negative type 1 diabetes share similar clinical, immunologic, genetic and metabolic features with those who are autoantibody-positive.
引用
- Patel SK, Ma CS, Fourlanos S, et al. Clinical, immunogenetic and metabolic characteristics of autoantibody-negative and autoantibody-positive type 1 diabetes. Diabetologia. 2025. PMID: 41214251. doi:10.1007/s00125-025-06580-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。